Moleculin Biotech, Inc.
MBRX
$0.5748
$0.00721.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.78% | -9.23% | -12.28% | -16.23% | -15.47% |
| Depreciation & Amortization | -6.15% | -4.62% | -2.34% | 3.20% | 4.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.25% | -7.33% | -10.09% | 4.16% | -10.26% |
| Operating Income | 8.25% | 7.33% | 10.09% | -4.16% | 10.26% |
| Income Before Tax | -5.50% | 13.40% | 26.89% | -14.77% | 14.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.50% | 13.40% | 26.89% | -14.77% | 14.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.50% | 13.40% | 26.89% | -14.77% | 14.02% |
| EBIT | 8.25% | 7.33% | 10.09% | -4.16% | 10.26% |
| EBITDA | 8.26% | 7.35% | 10.13% | -4.16% | 10.31% |
| EPS Basic | 62.09% | 56.64% | 53.92% | 13.80% | 23.57% |
| Normalized Basic EPS | 62.09% | 56.64% | 53.92% | 13.80% | 23.57% |
| EPS Diluted | 62.09% | 56.64% | 53.92% | 13.80% | 23.57% |
| Normalized Diluted EPS | 62.09% | 56.64% | 53.92% | 13.80% | 23.57% |
| Average Basic Shares Outstanding | 272.97% | 144.23% | 74.18% | 37.87% | 16.88% |
| Average Diluted Shares Outstanding | 272.97% | 144.23% | 74.18% | 37.87% | 16.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |